human clinical trial bpc-157 Wolverine Stack: Healing Faster with Peptides Wellness clinics promote the use

Colin Renaud, PA-C, a member of ILADS who has spoken at ILADS conferences on Lyme diagnosis, puts it plainly: almost every Lyme patient he treats has co-infections

A severe or prolonged B12 deficiency can cause severe neurological dysfunction and contribute to osteoporosis

It is classified as a research chemical, meaning: It cannot be legally marketed as a drug or supplement It is not recognized as "Generally Recognized as Safe" (GRAS) No New Drug Application (NDA) has been submitted It has not undergone the formal FDA approval process Research Chemical Status BPC-157 is available for purchase as a "research chemical" in most jurisdictions, with important caveats: Sold for "research purposes only" Not for human consumption (legally) No quality standards enforced by regulatory agencies Purity and identity depend entirely on supplier integrity International Regulations Regulatory status varies by country: United States : Research chemical, not approved for human use European Union : Not approved, status varies by member state Canada : Not approved for human use, research chemical Australia : Not approved, TGA Category 4 substance United Kingdom : Not approved for human use Sports and Competition BPC-157 is not specifically listed on the World Anti-Doping Agency (WADA) prohibited list, unlike TB-500

~ AlphaMD You're eight weeks into TRT

doi:10.3390/ijms19071987 5

BPC-157 accelerates repair of muscles, tendons, ligaments, and gut lining by stimulating blood vessel growth, collagen production, and reducing inflammation